Evidence map›Paper›PMID 39415655›Full record

ReviewActa neuropsychiatrica2024

Exploring the potential link between ΔFosB and

Shokouh Arjmand, Mehran Ilaghi, Mohammad Shafie'ei, Pedro H Gobira, Rodrigo Grassi-Oliveira, Gregers Wegener

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta neuropsychiatrica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shokouh ArjmandTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-5151-8702
Mehran IlaghiInstitute of Neuropharmacology, Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0002-6674-5406
Mohammad Shafie'eiFaculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Pedro H GobiraTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Rodrigo Grassi-OliveiraTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Gregers WegenerTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-0081-0068

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From a neuroscientific point of view, one of the unique archetypes of substance use disorders is its road to relapse, in which the reward system plays a crucial role. Studies on the neurobiology of substance use disorders have highlighted the central role of a protein belonging to the Fos family of transcription factors, ΔFosB. Relying on the roles ΔFosB plays in the pathophysiology of substance use disorders, we endeavour to present some evidence demonstrating that

Indexed as

AcetylcysteineCravingProto-Oncogene Proteins c-fosSubstance-Related DisordersAnimalsHumansRecurrenceAcetylcysteineProto-Oncogene Proteins c-fosN-acetylcysteinereinstatementrelapsesubstance use disordersΔFosB

Identifiers

PMID39415655
PMCPMC13130383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.